Michael Green, PhD, discusses a new method of assessing lymphoma subtypes utilizing the tumor microenvironment.

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

A new hydrogel-based platform to preserve live patient-derived tumor tissues in the lab could pave the way for faster, more ...

Low-grade serous ovarian cancer (LGSC), accounts for just 5% to 10% of all epithelial ovarian cancers, but its distinct biology makes it especially challenging to treat. While the origin of this ...

Cancer persists as a leading cause of mortality worldwide, underscoring the urgent need to decipher its molecular complexity for improved detection, ...